MSD Animal Health Receives Positive Final Opinion from European Medicines Agency for BRAVECTO™ (fluralaner) Spot-On for Cats and Dogs

Dateline City: MADISON, N.J. Only Spot-On Treatment for Fleas and Ticks Effective For 12 Weeks MADISON, N.J.--(BUSINESS WIRE)--MSD Animal Health (known as Merck Animal Health in the United States and Canada) today announced that the Committee for Medicinal Products for Veterinary Use (CVMP) of the European Medicines Agency has adopted a positive final opinion, recommending the granting of a marketing authorization for the veterinary medicinal product BRAVECTO™ (fluralaner) Spot-On for both cats and dogs. Language: English Contact: MSD Animal HealthMedia:Amy Firsching, +1-908-473-6357amy.firsching@merck.comorPam Eisele, +1-908-423-5042pamela_eisele@merck.com Ticker Slug: Ticker: MRK Exchange: NYSE read more
Source: Merck.com - Corporate News - Category: Pharmaceuticals Tags: Corporate News Animal Health Latest News Source Type: news